Discordant drug susceptibility for mycobacterium tuberculosis within families

Pediatric Infectious Disease Journal

Volumn 31, Issue 7, 2012, Pages 783-785

  Seddon, James A ^a,b   Jordaan, Annemie M ^c   Victor, Thomas C ^c   Schaaf, H Simon ^a,d  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Division of Molecular Biology and Human Genetics   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Children; Discordant; Resistant; Tuberculosis

Indexed keywords

AMIKACIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; TERIZIDONE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPIRATION BIOPSY; BACTERIAL STRAIN; BACTERIUM CULTURE; BCG VACCINATION; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; CLINICAL EXAMINATION; COUGHING; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FEVER; GASTRIC SUCTION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; SPUTUM CULTURE; THORAX RADIOGRAPHY; TUBERCULIN TEST; WEIGHT REDUCTION;

ANTITUBERCULAR AGENTS; CHILD, PRESCHOOL; FAMILY HEALTH; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84862771566     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182567c20     Document Type: Article

References (12)

1. World Health Organization, Geneva, Switzerland. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. WHO/HTM/TB/2006371, WHO/FCH/CAH/20067. 2006.
2. World Health Organization, Geneva, Switzerland. Guidlelines for the programmatic management of drug-resistant tuberculosis-Emergency update. WHO/HTM/TB/2008402. 2008.
3. Schaaf HS, Van Rie A, Gie RP, et al. Transmission of multidrug-resistant tuberculosis. Pediatr Infect Dis J. 2000;19:695-699. (Pubitemid 30644036)
4. Schaaf HS, Michaelis IA, Richardson M, et al. Adult-to-child transmission of tuberculosis: household or community contact? Int J Tuberc Lung Dis. 2003;7:426-431. (Pubitemid 36565411)
5. Verver S, Warren RM, Munch Z, et al. Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet. 2004;363:212-214. (Pubitemid 38114721)
6. Warren RM, Victor TC, Streicher EM, et al. Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med. 2004;169:610-614. (Pubitemid 38270897)
7. van Rie A, Victor TC, Richardson M, et al. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med. 2005;172:636-642. (Pubitemid 41232977)
8. Schaaf HS, Victor TC, Engelke E, et al. Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children. Eur J Clin Microbiol Infect Dis. 2007;26:203-205.
9. Warren RM, Streicher EM, Gey van Pittius NC, et al. The clinical relevance of Mycobacterial pharmacogenetics. Tuberculosis (Edinb). 2009;89:199-202.
10. Schaaf HS, Victor TC, Venter A, et al. Ethionamide cross-and co-resistance in children with isoniazid-resistant tuberculosis. Int J Tuberc Lung Dis. 2009;13:1355-1359.
11. World Health Organization, Geneva, Switzerland. Molecular Line Probe Assays for the rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Policy Statement. 2008. Available at: http://www. who.int/tb/features-archive/policy-statement.pdf. Accessed March 1, 2011.
12. World Health Organization, Geneva, Switzerland. Roadmap for folling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB. 2010. Available at: http://www.who.int/tb/laboratory/roadmap-xpert-mtb-rif-rev23dec2010. pdf. Accessed April 1, 2011.